The fibrin assay comparison trial (FACT): correlation of soluble fibrin assays with D-dimer
- PMID: 11816708
The fibrin assay comparison trial (FACT): correlation of soluble fibrin assays with D-dimer
Abstract
Soluble fibrin (SF) is regarded as an indicator of acute fibrin formation and a precursor of fibrin thrombi. Using a set of clinical plasma samples, and fibrin derivatives, five assays for measurement of SF, including two chromogenic assays, two ELISA systems, and one latex-enhanced photometric immunoassay were compared. Correlation between SF assays was moderate (Spearman's rho values between 0.344 and 0.805). Re-calibration with serial dilutions of desAABB-fibrin monomer resulted in adjustment of the numerical scale of the assays without improving correlation. All SF assays reacted with purified crosslinked fibrin derivatives. Using clinical plasma samples, Spearman's rho of SF assays with D-dimer consensus values based upon results of 23 quantitative D-dimer assays were between 0.491 and 0.911. Although all SF assays react with desAABB-fibrin monomer complexes, SF assays are heterogeneous concerning reactivity with fibrin compounds observed in clinical plasma samples. The prospect of a common calibrator for SF assays therefore seems to be remote. Since SF assays react with crosslinked fibrin derivatives, it is not possible to clearly distinguish between acute fibrin formation, and fibrin dissolution on the basis of the results of current SF assays.
Similar articles
-
The Fibrin Assay Comparison Trial (FACT): evaluation of 23 quantitative D-dimer assays as basis for the development of D-dimer calibrators. FACT study group.Thromb Haemost. 2001 Apr;85(4):671-8. Thromb Haemost. 2001. PMID: 11341504
-
Validation, calibration, and specificity of quantitative D-dimer assays.Semin Vasc Med. 2005 Nov;5(4):315-20. doi: 10.1055/s-2005-922476. Semin Vasc Med. 2005. PMID: 16302152 Review.
-
Reactivity of soluble fibrin assays with plasmic degradation products of fibrin and in patients receiving fibrinolytic therapy.Thromb Haemost. 1999 Dec;82(6):1722-9. Thromb Haemost. 1999. PMID: 10613661
-
Use of D-dimer assays in the diagnosis of venous thrombosis.Semin Thromb Hemost. 2000;26(6):631-41. doi: 10.1055/s-2000-13221. Semin Thromb Hemost. 2000. PMID: 11140800 Review.
-
The use of soluble fibrin in evaluating the acute and chronic hypercoagulable state.Thromb Haemost. 1999 Aug;82(2):673-83. Thromb Haemost. 1999. PMID: 10605767 Review.
Cited by
-
Formation and elimination of soluble fibrin and D-dimer in the bloodstream.Croat Med J. 2023 Dec 31;64(6):421-429. doi: 10.3325/cmj.2023.64.421. Croat Med J. 2023. PMID: 38168523 Free PMC article. Review.
-
D-dimer Testing in Pulmonary Embolism with a Focus on Potential Pitfalls: A Narrative Review.Diagnostics (Basel). 2022 Nov 12;12(11):2770. doi: 10.3390/diagnostics12112770. Diagnostics (Basel). 2022. PMID: 36428830 Free PMC article. Review.
-
Advances in D-dimer testing: progress in harmonization of clinical assays and innovative detection methods.Anal Bioanal Chem. 2024 Jul;416(16):3737-3750. doi: 10.1007/s00216-024-05207-x. Epub 2024 Mar 20. Anal Bioanal Chem. 2024. PMID: 38503987 Review.
-
Is it possible to make a common reference standard for D-dimer measurements? Communication from the ISTH SSC Subcommittee on Fibrinolysis.J Thromb Haemost. 2022 Feb;20(2):498-507. doi: 10.1111/jth.15555. Epub 2021 Nov 24. J Thromb Haemost. 2022. PMID: 34653304 Free PMC article.
-
New combinational assay using soluble fibrin and d-dimer determinations: a promising strategy for identifying patients with suspected venous thromboembolism.PLoS One. 2014 Mar 24;9(3):e92379. doi: 10.1371/journal.pone.0092379. eCollection 2014. PLoS One. 2014. PMID: 24664182 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources